Literature DB >> 7947995

CoA-independent transacylase activity is increased in human neutrophils after treatment with tumor necrosis factor alpha.

J D Winkler1, C M Sung, L Huang, F H Chilton.   

Abstract

CoA-independent transacylase (CoA-IT) appears to play a critical role in lipid mediator generation by rapidly moving arachidonate (AA) between phospholipid pools during cell activation. Tumor necrosis factor-alpha (TNF) pretreatment of human neutrophils increases agonist-induced production of inflammatory mediators. The current study tested if the TNF-induced increase in lipid mediator production may be, in part, due to altered CoA-IT activity. Neutrophils were treated with TNF (250 U/ml, 30 min), homogenates prepared, and CoA-IT activity measured by the ability of these homogenates to acylate 1-[3H]alkyl-2-lyso-sn-glycero-3-phosphocholine (GPC). There was an increased CoA-IT activity, from 9.1 +/- 1.1 to 13.7 +/- 1.4 pmol/mg per min in control vs. TNF-treated samples, respectively. Varying the concentration of 1-alkyl-2-lyso-GPC revealed an increased CoA-IT activity in microsomes that was due to an increased Vmax, from 26 to 54 pmol/mg per min. The ability of TNF to increase CoA-IT activity was concentration-dependent, with maximal response observed at 25 U/ml. This effect on CoA-IT appears to be specific, in that TNF treatment of neutrophils had no effect on CoA-dependent acylation of 1-acyl-2-lyso-sn-glycero-3-phosphocholine, using either AA-CoA or linolenoyl-CoA as substrates. In the intact cell, the movement of [3H]AA from other phospholipids into PE in fMLP-stimulated neutrophils was greatly enhanced after TNF treatment, demonstrating a functional consequence of increased CoA-IT activity. In addition, TNF treatment doubled platelet-activating factor production in response to the chemotactic peptide fMLP, as measured by [3H]acetate incorporation, while the response to A23187 remained unchanged. Taken together, these results provide the first evidence of modulation of CoA-IT activity by a proinflammatory cytokine and suggest that one mechanism for augmented lipid mediator formation is through increases in CoA-IT activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947995     DOI: 10.1016/0005-2760(94)90102-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  A human cDNA sequence with homology to non-mammalian lysophosphatidic acid acyltransferases.

Authors:  A C Stamps; M A Elmore; M E Hill; K Kelly; A A Makda; M J Finnen
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 2.  Regulation and metabolism of arachidonic acid.

Authors:  M C Seeds; D A Bass
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

3.  Fatty acid remodeling in cellular glycerophospholipids following the activation of human T cells.

Authors:  Philippe Pierre Robichaud; Katherine Boulay; Jean Éric Munganyiki; Marc E Surette
Journal:  J Lipid Res       Date:  2013-07-26       Impact factor: 5.922

Review 4.  Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.

Authors:  Atsushi Yamashita; Yasuhiro Hayashi; Naoki Matsumoto; Yoko Nemoto-Sasaki; Takanori Koizumi; Yusuke Inagaki; Saori Oka; Takashi Tanikawa; Takayuki Sugiura
Journal:  Biology (Basel)       Date:  2017-03-30

5.  Arachidonoyl-phospholipid remodeling in proliferating murine T cells.

Authors:  Michiyo Tomita; Rodney C Baker; Soichiro Ando; Thomas J Santoro
Journal:  Lipids Health Dis       Date:  2004-01-30       Impact factor: 3.876

6.  Cellular Plasmalogen Content Does Not Influence Arachidonic Acid Levels or Distribution in Macrophages: A Role for Cytosolic Phospholipase A2γ in Phospholipid Remodeling.

Authors:  Patricia Lebrero; Alma M Astudillo; Julio M Rubio; Lidia Fernández-Caballero; George Kokotos; María A Balboa; Jesús Balsinde
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.